Profile | GDS4284 / 224009_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 422.762 | 62 |
GSM687648 | Patient 402 control | 216.487 | 50 |
GSM687653 | Patient 403 control | 225.007 | 52 |
GSM687658 | Patient 404 control | 1401.49 | 79 |
GSM687663 | Patient 411 control | 383.375 | 59 |
GSM687668 | Patient 422 control | 678.222 | 68 |
GSM687673 | Patient 424 control | 446.555 | 61 |
GSM687678 | Patient 425 control | 481.541 | 62 |
GSM687683 | Patient 427 control | 285.181 | 53 |
GSM687688 | Patient 428 control | 148.916 | 42 |
GSM687695 | Patient 441 control | 3616.52 | 91 |
GSM687699 | Patient 443 control | 883.02 | 72 |
GSM687704 | Patient 444 control | 149.134 | 42 |
GSM687707 | Patient 448 control | 292.8 | 53 |
GSM687712 | Patient 449 control | 506.48 | 64 |
GSM687719 | Patient 450 control | 972.334 | 73 |
GSM687724 | Patient 451 control | 294.146 | 54 |
GSM687728 | Patient 452 control | 892.072 | 73 |
GSM687646 | Patient 401 treated 24h | 304.981 | 55 |
GSM687649 | Patient 402 treated 24h | 390.76 | 60 |
GSM687665 | Patient 411 treated 24h | 486.711 | 62 |
GSM687651 | Patient 402 treated 4 weeks | 145.747 | 41 |
GSM687667 | Patient 411 treated 4 weeks | 182.234 | 46 |
GSM687670 | Patient 422 treated 24h | 781.736 | 70 |
GSM687671 | Patient 422 treated 4 weeks | 668.646 | 68 |
GSM687654 | Patient 403 treated 24h | 236.224 | 53 |
GSM687675 | Patient 424 treated 24h | 599.595 | 66 |
GSM687685 | Patient 427 treated 24h | 284.734 | 54 |
GSM687656 | Patient 403 treated 4 weeks | 145.485 | 45 |
GSM687677 | Patient 424 treated 4 weeks | 241.14 | 52 |
GSM687687 | Patient 427 treated 4 weeks | 205.581 | 50 |
GSM687692 | Patient 428 treated 4h | 245.302 | 52 |
GSM687716 | Patient 449 treated 4h | 437.315 | 62 |
GSM687722 | Patient 450 treated 4h | 565.834 | 65 |
GSM687680 | Patient 425 treated 24h | 267.493 | 53 |
GSM687690 | Patient 428 treated 24h | 157.298 | 45 |
GSM687700 | Patient 443 treated 24h | 1926.16 | 84 |
GSM687705 | Patient 444 treated 24h | 289.354 | 56 |
GSM687714 | Patient 449 treated 24h | 467.736 | 63 |
GSM687721 | Patient 450 treated 24h | 999.659 | 74 |
GSM687682 | Patient 425 treated 4 weeks | 286.341 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 172.619 | 47 |
GSM687702 | Patient 443 treated 4 weeks | 641.361 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 462.292 | 63 |
GSM687723 | Patient 450 treated 4 weeks | 327.184 | 56 |
GSM687661 | Patient 404 treated 4h | 1266.05 | 77 |
GSM687710 | Patient 448 treated 4h | 314.888 | 57 |
GSM687726 | Patient 451 treated 4h | 219.003 | 47 |
GSM687730 | Patient 452 treated 4h | 379.321 | 47 |
GSM687660 | Patient 404 treated 24h | 16470.4 | 98 |
GSM687697 | Patient 441 treated 24h | 3990.15 | 92 |
GSM687709 | Patient 448 treated 24h | 267.927 | 53 |
GSM687725 | Patient 451 treated 24h | 484.383 | 62 |
GSM687729 | Patient 452 treated 24h | 2386.74 | 87 |
GSM687727 | Patient 451 treated 4 weeks | 279.314 | 52 |
GSM687731 | Patient 452 treated 4 weeks | 1341.89 | 78 |